Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-166.67% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
GBR · Mar 31, 2026
New Concept Energy, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001214659-26-005713General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
2.63% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-130.77% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History18 statesSelf-history eligible
Mar 31, 20210/3 normalizedLevel 3Mar 31, 20220/3 normalizedLevel 3Jun 30, 20220/3 normalizedLevel 3Dec 31, 20222/3 normalizedLevel 3Mar 31, 20232/3 normalizedLevel 3Jun 30, 20232/3 normalizedLevel 3Sep 30, 20232/3 normalizedLevel 3Dec 31, 20232/4 normalizedLevel 3Mar 31, 20243/3 normalizedLevel 3Jun 30, 20243/3 normalizedLevel 3Sep 30, 20243/3 normalizedLevel 3Dec 31, 20243/4 normalizedLevel 3Mar 31, 20253/3 normalizedLevel 3Jun 30, 20253/3 normalizedLevel 3Sep 30, 20253/3 normalizedLevel 3Dec 31, 20253/3 normalizedLevel 3Mar 31, 20263/3 normalizedLevel 3Jun 30, 20263/3 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 12.90%
- Current
- -166.67%
- Delta
- -179.57%
- Previous
- 6.16%
- Current
- 2.63%
- Delta
- -3.53%
- Previous
- -170.97%
- Current
- -130.77%
- Delta
- 40.20%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.